529
Participants
Start Date
February 7, 2014
Primary Completion Date
June 17, 2019
Study Completion Date
June 21, 2024
Nivolumab
specified dose on specified days
Bevacizumab
specified dose on specified days
Ipilimumab
specified dose on specified days
Local Institution - 0050, Brussels
Local Institution, Brussels
Local Institution - 0051, Brussels
Local Institution, Brussels
Local Institution - 0035, Liverpool
Local Institution, Liverpool
Local Institution - 0033, Heidelberg
Local Institution, Heidelberg
Local Institution - 0034, East Bentleigh
Local Institution, East Bentleigh
Local Institution - 0057, Odense C
Odense University Hospital, Odense C
Local Institution - 0032, Nedlands
Local Institution, Nedlands
Aarhus University Hospital, Aarhus C
Local Institution - 0058, Aarhus C
Local Institution - 0040, Zurich
UniversitaetsSpital Zurich, Zurich
Local Institution - 0003, New York
Memorial Sloan Kettering Cancer Center, New York
Azienda Ospedaliera Citta della Salute e della Scienza, Torino
Local Institution - 0013, Torino
Local Institution - 0063, Marseille
Local Institution, Marseille
Thomas Jefferson University - Clinical Research Institute, Philadelphia
Thomas Jefferson University, Philadelphia
Georgetown University, Washington D.C.
Local Institution - 0011, Milan
Local Institution, Milan
Johns Hopkins University School Of Medicine, Baltimore
Local Institution - 0008, Baltimore
University Of Virginia Health System, Charlottesville
Local Institution - 0007, Durham
Preston Robert Tisch Brain Tumor Center at Duke University, Durham
Local Institution - 0045, Madrid
Local Institution, Madrid
Local Institution - 0046, Madrid
Local Institution, Madrid
Levine Cancer Institute, Charlotte
Local Institution - 0023, Charleston
Medical University Of South Carolina, Charleston
Local Institution - 0002, Atlanta
Winship Cancer Institute, Atlanta
Local Institution - 0070, Pamplona
Local Institution, Pamplona
Moffitt Cancer Center, Tampa
Local Institution - 0005, Nashville
Vanderbilt University Medical Center, Nashville
Local Institution - 0010, Bologna
Local Institution, Bologna
Local Institution - 0049, Cleveland
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic, Cleveland
Local Institution - 0041, Münster
Universitaetsklinikum Muenster, Münster
Henry Ford Health System, Detroit
Local Institution - 0012, Siena
Local Institution, Siena
Local Institution - 0037, Bonn
Universitaetsklinikum Bonn, Bonn
Mayo Clinic, Rochester
Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main, Frankfurt am Main
Local Institution - 0036, Frankfurt am Main
Local Institution - 0038, Heidelberg
Local Institution, Heidelberg
Local Institution - 0062, Bron
Local Institution, Bron
Local Institution - 0068, Paris
Local Institution, Paris
Local Institution - 0064, Paris
Local Institution, Paris
Anschutz Cancer Pavilion, Aurora
Local Institution - 0021, Aurora
Cedars Sinai Medical Center, Los Angeles
Local Institution - 0055, Los Angeles
University of Washington - Seattle Cancer Care Alliance, Seattle
Local Institution - 0020, Seattle
Swedish Neuroscience Institute, Seattle
University of Alabama at Birmingham, Birmingham
Local Institution - 0009, Los Angeles
UCLA Neuro-Oncology Program, Los Angeles
Local Institution - 0014, San Francisco
The Regents of the University of California, San Francisco, San Francisco
Local Institution - 0001, New Haven
Yale University School Of Medicine, New Haven
Beth Israel Deaconess Med Ctr, Boston
Dana-Farber Cancer Institute, Boston
Local Institution - 0006, Boston
Local Institution - 0043, Boston
Local Institution - 0056, Boston
Massachusetts General Hospital, Boston
Henry Ford Health System, Detroit
Local Institution - 0024, Houston
University Of Texas Md Anderson Cancer Ctr, Houston
Local Institution - 0067, Amsterdam
Local Institution, Amsterdam
Local Institution - 0066, Groningen
Local Institution, Groningen
Local Institution - 0060, Gdansk
Local Institution, Gdansk
Local Institution - 0059, Warsaw
Local Institution, Warsaw
Local Institution - 0047, Barcelona
Local Institution, Barcelona
Centre hospitalier universitaire Vaudois (CHUV), Lausanne
Local Institution - 0039, Lausanne
Local Institution - 0018, London
Local Institution, London
Local Institution - 0015, Manchester
Local Institution, Manchester
Local Institution - 0017, Liverpool
Local Institution, Liverpool
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY